Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma

Fig. 2

Survival analysis of UBE2I in KIRC, LIHC and STAD determined by Kaplan–Meier plotter database. a The prognostic value (OS) of UBE2I in KIRC. b The prognostic value (RFS) of UBE2I in KIRC. c The prognostic value (OS) of UBE2I in LIHC. d The prognostic value (RFS) of UBE2I in LIHC. e The prognostic value (OS) of UBE2I in STAD. f The prognostic value (RFS) of UBE2I in STAD. Note: OS, overall survival; RFS, relapse free survival. Logrank P-value < 0.05 was considered as statistically significant

Back to article page